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Cytosolic detection of microbial products is essen-
tial for the initiation of an innate immune response
against intracellular pathogens such as Mycobac-
terium tuberculosis (Mtb). During Mtb infection of
macrophages, activation of cytosolic surveillance
pathways is dependent on the mycobacterial
ESX-1 secretion system and leads to type I inter-
feron (IFN) and interleukin-1b (IL-1b) production.
Whereas the inflammasome regulates IL-1b secre-
tion, the receptor(s) responsible for the activation
of type I IFNs has remained elusive. We demon-
strate that the cytosolic DNA sensor cyclic
GMP-AMP synthase (cGAS) is essential for initiating
an IFN response to Mtb infection. cGAS associates
with Mtb DNA in the cytosol to stimulate cyclic
GAMP (cGAMP) synthesis. Notably, activation of
cGAS-dependent cytosolic host responses can be
uncoupled from inflammasome activation by
modulating the secretion of ESX-1 substrates. Our
findings identify cGAS as an innate sensor of
Mtb and provide insight into how ESX-1 controls
the activation of specific intracellular recognition
pathways.
INTRODUCTION
Tuberculosis (TB) is a major cause of morbidity and mortality
worldwide (Lechartier et al., 2014). Upon infection with Myco-
bacterium tuberculosis (Mtb), several factors contribute to
the outcome of the disease, with the innate immune response
representing one of the most critical determinants. To date
several cytokines have been shown to participate in the innate
host response against Mtb, where they can either function to
confer host resistance or act as regulatory molecules that
may exacerbate the infection (O’Garra et al., 2013). Studies
have established the critical role of inflammatory cytokines,
such as interleukin-1b (IL-1b), in the containment of Mtb byCell Henhancing the antimicrobial function of macrophages (Fremond
et al., 2007). On the contrary, animal models and studies in hu-
mans have revealed that type I interferons (IFNs) have probac-
terial activity and are associated with disease progression in TB
(Berry et al., 2010; Manca et al., 2005; Stanley et al., 2007). The
immunomodulatory effect of type I IFNs appears to be related
to their anti-inflammatory properties, principally by antago-
nizing the production and activity of IL-1b (Mayer-Barber
et al., 2011).
A key feature of pathogenic mycobacteria is the type VII secre-
tion system ESX-1 that manipulates innate immune responses,
presumably by translocating bacterial effector molecules into
the host cytosol (Stoop et al., 2012). In macrophages intracellular
detection of Mtb-associated molecular patterns is regulated via
two major sensing systems that are linked to distinct signaling
pathways. One pathway involves the multimeric inflammasome
complex, which employs a sensor molecule, NLRP3 or AIM2,
the adaptor ASC, and caspase-1 to regulate the secretion of
IL-1b (Mishra et al., 2010; Saiga et al., 2012). Whereas AIM2 rec-
ognizes DNA, the NLRP3 inflammasome is stimulated by a
mechanism involving K+ efflux (Dorhoi et al., 2012). The second
pathway, which is responsible for the expression of type I IFNs,
relies on the cyclic dinucleotide (CDN) sensor STING (Manzanillo
et al., 2012). Within this pathway, activation of STING by
CDNs recruits the kinase TBK-1, which phosphorylates the
transcription factor IRF-3 to promote transcription of IFN-b and
interferon-stimulated genes (ISGs). Notably, during intracellular
bacterial infection activation of STING can be accomplished
via two differential mechanisms. First, STING can directly recog-
nize bacterial CDNs and thus function as a primary pattern
recognition receptor (PRR) (Burdette et al., 2011). Alternatively,
DNA sensing via cGAS triggers the synthesis of the second
messenger cGAMP, which then engages STING as a secondary
receptor (Sun et al., 2013). But despite these advances in under-
standing the downstream part of these signaling cascades, the
molecular events that lead to ESX-1-dependent activation of
intracellular host receptors and the nature of the stimulatory ele-
ments remain poorly defined.
Here we report that the DNA sensor cGAS is essential
for mounting type I IFN responses upon Mtb infection. We
show that ESX-1-proficient mycobacteria trigger cGAS to form
intracellular complexes that colocalize with DNA and promoteost & Microbe 17, 799–810, June 10, 2015 ª2015 Elsevier Inc. 799
intercellular signal transduction via the production of cGAMP.
Remarkably, by comparing the cytokine profile induced by
distinct ESX-1 mutants, we observed that intracellular inflamma-
some-dependent and cGAS-mediated responses can be
disconnected. Together, these data reveal the importance of
cGAS in controlling interferon production upon mycobacterial
infection and uncover a unique function of ESX-1 in eliciting spe-
cific innate immune responses.
RESULTS
cGAS Is Critical for IFN Responses upon Mtb Infection
In order to investigate the individual role of cytosolic PRRs during
infection with Mtb in human cells, we employed human THP-1
cells, in which STING was knocked out via the CRISPR/Cas9
technology (see Figure S1A online). Similar to what had
previously been shown in murine macrophages, we found that
Mtb-triggered production of IP-10, a surrogate cytokine for
type I IFN expression, was completely compromised in human
THP-1 cells lacking STING (Figure S1B). The samewas observed
when gene expression of IFN-b was directly analyzed by qPCR
(Figure S1C). We furthermore noted that transfection of Mtb
genomic DNA regulated the induction of IP-10 via STING (Fig-
ure S1D). Recently, Rv3586 was identified as a mycobacterial
diadenylate cyclase, DacA, which synthesizes cyclic di-AMP
(Bai et al., 2012). Overexpression of DacA in conjunction with
STING in HEK293T cells induced robust transactivation of an
IFN-b reporter gene (Figure S1E). This effect was abolished
when endogenous cyclic di-AMP levels were reduced by the
activity of the cyclic di-AMP-specific phosphodiesterase YybT
(Figure S1F) (Rao et al., 2010). In line with this, DacA was unable
to activate IFN-b upregulation when coexpressed with a STING
variant that cannot sense cyclic di-AMP (data not shown).
Finally, purified cyclic di-AMP also triggered IP-10 production
in THP-1 cells in a STING-dependent fashion (Figure S1G).
Together, these data confirm STING-mediated DNA/CDN
sensing in human macrophages, but they also illustrate that
during Mtb infection both mycobacterial cyclic di-AMP and
genomic DNA may serve as the molecular pattern that initiates
type I IFN induction.
To definitively clarify the role of DNA- versus CDN-mediated
IFN regulation in Mtb-infected cells, we employed THP-1 cells
knocked out for cGAS (Figure 1A). Using these cell lines we
examined the role of cGAS in the innate recognition of Mtb. As
expected, cGAS knockout cells did not activate a type I IFN
response upon transfection with dsDNA (Figure 1B). As controls,
cGAS knockout cell lines were not compromised in their
response toward the RIG-I ligand triphosphate RNA or the
STING agonists cGAMP or cyclic di-AMP (Figures 1B, S1H,
and S1J and data not shown). Importantly, when infected
with Mtb, cGAS knockout cells failed to mount a detectable
level of IP-10 and IFN-b production (Figures 1C and S1K). More-
over, gene expression of IFN-b or the ISG IFIT2 was also
completely absent in cGASmutant cells afterMtb challenge (Fig-
ure 1D). To explore the relevance of cGAS for the immune
response in murine cells, we infected bone marrow-derived
macrophages (BMDMs) from cGAS/mice and compared their
type I IFN response with that of wild-type macrophages.
Whereas comparable levels of IP-10 and IFN-b were induced800 Cell Host & Microbe 17, 799–810, June 10, 2015 ª2015 Elsevierafter stimulation with triphosphate RNA or cGAMP, BMDMs
derived from cGAS/ animals were almost completely unre-
sponsive in terms of IP-10 and type I IFN production upon Mtb
infection (Figures 1E and S1I). To provide definitive proof of the
involvement of cGAS in the innate response toMtb, we reconsti-
tuted cGAS knockout cells with a human Flag-tagged cGAS
construct via lentivirus-mediated transduction, whereas a Flag-
tagged GFP construct served as a control. In cells transduced
with the cGAS construct, cGAS protein expression was restored
to a level comparable to that of wild-type cells (Figure 1F).
Consistently, when transfected with dsDNA, reconstituted
THP-1 cells produced comparable levels of IP-10 and displayed
similar induction of IFN-b or IFIT2 as wild-type cells (Figure 1G
and data not shown). Importantly, expression of cGAS-Flag
but not GFP-Flag restored the ability of cGAS-deficient cells to
respond to Mtb infection (Figure 1G). To assess the biological
role of the cGAS-STING-IFN-b pathway on Mtb virulence, we
compared the cytotoxicity caused by two different Mtb strains,
H37Rv and HN878, on wild-type, cGAS-deficient, and STING-
deficient cell lines. HN878 is a clinical isolate belonging to the
East Asia (W-Beijing) family, while H37Rv is a member of the
Euro-American lineage (Reed et al., 2007). Notably, HN878 has
been described as capable of inducing higher levels of type
I IFN in themurinemodel of infection (Manca et al., 2005). Testing
these strains confirmed the increased production of IP-10 by
wild-type cells after HN878 challenge, while deletion of cGAS
or STING abolished this response (Figure S2A). We observed
that cell survival was partially rescued by cGAS and STING
knockout cells upon HN878 infection (Figure S2B). Together,
these results demonstrate that cGAS is crucial for the innate
type I IFN response in both human and murine macrophages
infectedwithMtb. In addition, these findings suggest that dsDNA
but not CDNs functions as the mycobacteria-associated pattern
required for IFN regulation.
cGAS Associates with DNA in the Cytosol
To further characterize the molecular mechanism of Mtb-driven
cGAS activation, we examined the localization of cGAS in
THP-1 cells by immunofluorescence microscopy. In untreated
cells cGAS was distributed diffusely throughout the cytoplasm
(Figure 2A). After transfection with dsDNA we observed
cGAS forming punctate structures that colocalized with DNA
(Figure 2A). Interestingly, the formation of these structures was
specifically induced upon stimulation with DNA, but not after
transfection with the endogenous cGAS enzymatic product
cGAMP or triphosphate RNA (Figure S3). Strikingly, upon infec-
tion withMtb we observed significant formation of cGAS aggre-
gates, which colocalized with DNA (Figure 2A). In contrast, cells
infectedwith an attenuatedMtb strain, H37RvDRD1, which lacks
IFN-stimulatory capacity due to loss of ESX-1 (see below), failed
to stimulate cGAS punctate structure formation (Figure 2A). In
addition, we found that pretreatment of cells with chloroquine,
an inhibitor of autophagy, interfered with both DNA- and Mtb-
triggered cGAS redistribution, suggesting the involvement of
the autophagy machinery for the execution of the cGAS relocal-
ization process (Figure 2B). In accordancewith this notion and as
previously described, the observed cGAS punctate structures
colocalized with the autophagy-related protein Beclin-1, but
not with the inflammasome complex (Figure 2C) (Liang et al.,Inc.
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Figure 1. cGAS Is Essential for Type I IFN Responses Triggered by Mtb
(A) Expression of cGAS was studied in wild-type (WT) THP-1 cells and two distinct cGAS knockout cell lines by immunoblot.
(B) WT THP-1 cells, cGAS, and STING knockout cells were transfected with cGAMP, dsDNA, or 50-triphosphate RNA (50-pppRNA). IP-10 production was
measured by ELISA 24 hr after stimulation.
(C and D)WT THP-1 cells and cGAS knockout cells were infected with H37Rv (multiplicity of infection [moi] 5, 10) or stimulated with 50-pppRNA as indicated. After
24 hr IP-10 levels were assessed by ELISA (C) or IFN-b and IFIT2 mRNA levels were quantified by qPCR (D).
(E) ELISA measurement of IP-10 from the supernatants of BMDMs from WT mice and cGAS knockout mice after overnight culture left untreated, infected with
H37Rv (moi 2.5, 5, and 10) or stimulated with cGAMP or 50-pppRNA.
(F) Immunoblot of reconstituted cGAS-deficient cell lines (cGAS). Transduction of GFP served as a control (GFP).
(G)WT THP-1 cells and cells from (F) were left untreated, infected with H37Rv (moi 10) or transfected with dsDNA. After 24 hr mRNA levels of IFN-b and IFIT2 were
measured by qPCR.
Mean + SD of duplicate measurements from one representative experiments out of four (B), three (C), or two (D, E, and G) independent experiments are depicted,
or representative results from two independent experiments are shown (A and F). p < 0.05 (*); p < 0.01 (**). See also Figures S1 and S2.2014). Together, this shows that infection of macrophages with
Mtb leads to cytosolic association of cGAS and DNA.
Dissemination of theMtb-Triggered Host Response
through cGAMP-Based Intercellular Communication
Next we assessed whether Mtb infection leads to the synthesis
of cGAMP within human macrophages. Toward this goal we
took advantage of the fact that cGAMP can activate bystander
cells via its horizontal transfer through gap junctions (Ablasser
et al., 2013b). We hypothesized that, even though individual
cGAS or STING knockout cells are unable to upregulate type
I IFNs in a cell-intrinsic fashion, the combination of both would
restore this response upon DNA transfection or Mtb infection if
cGAMP were produced (Figure 3A, left, and Figure 3C, left).Cell HIndeed, when activated by transfection with dsDNA, mono-
cultures of both cGAS- or STING-deficient cells failed to elicit
type I IFN induction, yet the combination of both cell types
resulted in marked upregulation of IFN-b or IFIT2 gene
expression (Figure 3A, right, and data not shown). Consistent
with a gap junction-dependent mode of transfer, this effect
was abolished upon pretreating the mixed cocultures with the
connexin inhibitor carbenoxolone (Figure 3B). We then
tested whether cGAMP-dependent in trans signaling would
also occur in the context ofMtb infection (Figure 3C, left). Similar
to the results obtained above, coculturing of cGAS- or STING-
deficient cells led to strong upregulation of IFN-b mRNA levels
and of IFN-b secretion (Figure 3C, right, and Figure 3E). Again,
this phenomenon was sensitive to carbenoxolone treatmentost & Microbe 17, 799–810, June 10, 2015 ª2015 Elsevier Inc. 801
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Figure 2. Upon Mtb Infection cGAS Forms Aggregates and
Colocalizes with DNA
(A and B) THP-1 cells stably expressing cGAS-Flag were seeded on coverslips
and treated as depicted. Sixteen hours after dsDNA transfection or 48 hr after
Mtb infection in the absence (A) or presence of 50 mM chloroquine (B), cells
were stained for Flag-tagged cGAS (green) and nuclei/DNA (DAPI, blue).
(C) Cells were stained for Flag-tagged cGAS (green), ASC or Beclin-1 (red), and
nuclei/DNA (DAPI, blue). Scale bar, 5 mm; right, magnification of area outlined.
Arrows highlight spots of DNA and cGAS colocalization.
Representative images out of three independent experiments are shown. See
also Figure S3 and Table S1.(Figure 3D). These results reveal that during Mtb infection
macrophages produce cGAMP. Furthermore, this suggests
that the detection of Mtb can be relayed from infected macro-802 Cell Host & Microbe 17, 799–810, June 10, 2015 ª2015 Elsevierphages to noninfected neighboring cells via gap-junction-medi-
ated communication.
Comparison of ESX-1- and cGAS-Regulated Cytokine
Responses
We next sought to better characterize the molecular events
that lead to DNA-dependent activation of cGAS. To this end
we analyzed a selection of cytokines, which are known as
central mediators of the in vivo response toward Mtb infection,
including TNF-a, IL-1b, and IL-10. Besides using the wild-type
Mtb strain H37Rv, macrophages were also infected with the
attenuated vaccine strain Mycobacterium bovis BCG, which
lacks the ESX-1 protein secretion system, known to be
required for type I IFN responses (Stanley et al., 2007). As ex-
pected, macrophages only produced type I IFN and the
related cytokines IP-10 and IL-10 after infection with H37Rv,
but not with BCG (Figures 4A and 4C). In addition, upon
analyzing the levels of IP-10 and IL-10 from wild-type,
cGAS-deficient, and STING-deficient cells, we observed that
expression of IP-10 and IL-10 was equally affected in the
knockout cell lines (Figure 4B), thereby confirming that ESX-
1- and DNA/cGAS-dependent cytokines are coregulated. On
the other hand, production of the proinflammatory cytokines
TNF-a and IL-6 was similarly triggered by both strains (Fig-
ure 4A and data not shown) and not altered in the mutant
cell lines as compared to the wild-type cells (Figure 4B). How-
ever, these congruent patterns differed when IL-1b production
was assessed. Whereas BCG failed to promote IL-1b secre-
tion, absence of cGAS or STING did not compromise IL-1b
secretion following H37Rv infection (Figures 4A and 4B).
These findings can be explained by the inflammasome-medi-
ated regulation of IL-1b, which reportedly also involves an
ESX-1-dependent mechanism of activation (Kurenuma et al.,
2009). In this regard it is interesting to note that the stimulation
of the inflammasome by Mtb also appears to involve a sensing
mechanism relying on the detection of intracellular DNA via
AIM2 (Saiga et al., 2012). However, studies also reported
NLRP3 as the main mediator of inflammasome activation
through a mechanism triggered via K+ efflux (Dorhoi et al.,
2012; Kurenuma et al., 2009; Mishra et al., 2010). To elucidate
the individual roles of these factors, we targeted AIM2 and the
shared inflammasome adaptor molecule ASC in THP-1 cells.
We found that the absence of AIM2 reduced IL-1b levels to
50% in response to Mtb infection, while the absence of
ASC completely abrogated the IL-1b signal (Figure S4A).
Type I IFN responses in both AIM2- and ASC-mutated cells
were comparable to those of wild-type cells (Figure S4A).
Importantly, inhibition of NLRP3 via blocking K+ efflux by gli-
benclamide entirely blocked the residual secretion of IL-1b in
AIM2 knockout cells, indicating that Mtb-triggered activation
of the inflammasome complex in human macrophages is
mediated by the collective actions of AIM2 and NLRP3 (Fig-
ure S4B). So far, our data suggest that during infection with
virulent tubercle bacilli two intracellular DNA sensing sys-
tems—cGAS and AIM2—become activated, each inducing a
complementary cytokine response—type I IFNs and IL1-b,
respectively. In addition, more than one ESX-1-controlled
mechanism operates in Mtb-infected cells to trigger IL-1b
release via an inflammasome-dependent mechanism.Inc.
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Figure 3. cGAMP Shuttling through Gap Junctions Restores Type I IFN Responses upon Mtb Infection in Mixed Cocultures
(A and C) (Left) Scheme depicting model of horizontal transfer of cGAMP upon DNA transfection (A) or H37Rv infection (C); (right) mono- and cocultures (as
indicated) of WT THP-1 cells, cGAS-deficient cells, or STING-deficient cells, which were left untreated or stimulated via DNA transfection (A) or H37Rv infection
(moi 10) (C). After 24 hr, mRNA levels of IFN-b were measured by qPCR.
(B and D) Cocultures of cGAS- and STING-deficient THP-1 cells were left untreated or transfected with DNA (B), or infected with H37Rv (moi 10) (D) in the
presence or absence of carbenoxolone (CBX; 100 mM) as indicated. mRNA levels of IFN-b were assessed by qPCR after 24 hr.
(E) Type I IFN was measured 24 hr postinfection of mono- and cocultures of WT THP-1 cells, cGAS-deficient cells, and STING-deficient cells.
Mean + SD of duplicate measurements of representative results from two independent experiments is depicted. **p < 0.01.
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A B C Figure 4. Virulent and Attenuated
Mycobacteria Differentially Activate Innate
Cytokine Responses
(A and C) THP-1 cells were infected with H37Rv
and BCG (moi 10).
(B) WT THP-1 cells, cGAS-deficient cells, or
STING-deficient THP-1 cells were infected with
H37Rv (moi 10). After 24 hr supernatants were
assessed by ELISA for production of IP-10, IL-10,
TNF-a, IL-1b, or IFN-b.
Mean + SD of duplicate measurements of repre-
sentative results from three independent experi-
ments is depicted. **p < 0.01. See also Figure S4
and Table S1.Mutations within ESX-1 Abrogate cGAS-Dependent IFN
Responses
To further explore the role of ESX-1 for the stimulation of intracel-
lular signaling pathways, we tested distinctmycobacterial strains
for their capability to induce type I IFNs or IL-1b responses, which
we speculated to be coregulated and used as an indirect means
to monitor the functionality of the secretory system. First, we
focused on the region of difference 1 (RD1) locus, given that its
loss led to the attenuation of BCG (Pym et al., 2002). Next to
strains harboring disruptions of the entire and extended RD1
locus, H37RvDRD1 and H37RvDDRD1 (Bottai et al., 2011),
respectively, we also tested the attenuated H37Ra strain of
Mtb, which carries the S129L mutation in the transcriptional
regulator phoP and is defective for secretion of EsxA, a major
substrate of ESX-1 (Frigui et al., 2008). Analyzing cytokine
levels of infected macrophages, we observed that none of the
mutant strains were able to activate IP-10 production and, as ex-
pected from the experiments above, both H37RvDRD1 and
H37RvDDRD1 were impaired in inducing IL-1b secretion (Fig-
ure 5A). Surprisingly, infection with H37Ra still led to significant
release of IL-1b, even though no IP-10was produced (Figure 5A).804 Cell Host & Microbe 17, 799–810, June 10, 2015 ª2015 Elsevier Inc.Furthermore, we found that the residual
IL-1b response upon H37Ra infection
was profoundly reduced upon pretreat-
ment with glibenclamide (Figure 5B). This
suggests that H37Ra can still stimulate
the cytosolic sensor NLRP3, despite its
inability to trigger cytosolic DNA-sensing
pathways based on AIM2 and cGAS. To
confirm the physiological relevance of
this finding, we infected primary human
macrophages with H37Ra, which consis-
tently resulted in the secretion of IL-1b,
while at the same time IP-10 production
was markedly reduced (Figure 5C). These
results indicate that ESX-1-dependent
activation of two central yet opposite
host responses can be uncoupled.
Dissecting the Activation of
Intracellular Host Sensors by
Manipulating ESX-1
The above results indicate that secretion
of EsxA or another ESX-1 substrate isan essential feature for activating intracellular DNA-sensing
pathways in macrophages. In contrast to the strains BCG or
H37RvDRD1, in which the genes encoding EsxA are deleted,
the undetectable secretion of EsxA inH37Ra is achieved by an in-
direct mechanism involving lack of PhoP-mediated expression of
the espACD operon, a region distal to the RD1 locus but required
for full ESX-1 function (Figure 6A, right) (Stoop et al., 2012). To
directly assess the contribution of the EspA/C substrates, we
used the respective espA and espC mutants, with and without
complementation, to analyze the host cytokine response (Chen
et al., 2012). Compared to the wild-type strain or the respective
complemented strains, both mutants failed to trigger IP-10 pro-
duction upon infection of macrophages (Figure 6A left). In
contrast, we observed significant levels of IL-1b production (Fig-
ure 6B). Consistentwith the involvement of NLRP3 for this cellular
response, the IL-1b signal triggered by both EspA/C-deficient
strains was inhibited by glibenclamide (Figure 6C). Thus, we
conclude that EsxA secretion is essential for provoking intracel-
lular DNA sensing pathways and that reducing the EsxA levels
in the secreted fraction by genetic means does not abolish the
cytosolic activation of the NLRP3 inflammasome. These findings
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Figure 5. Intracellular Recognition Pathways Are Differentially Activated by Virulent and Attenuated M. tuberculosis
(A and C) THP-1 cells (A) or primary human macrophages (C) were infected with the following bacterial strains: H37Rv, H37RvDRD1, H37RvDDRD1, or H37Ra
(moi 2.5, 5, and 10). After 24 hr, IP-10 and IL-1b levels were assessed by ELISA.
(B) ELISA measurement of IL-1b in the supernatant of THP-1 cells after 24 hr of infection with H37Ra (moi 10) in the presence of glibenclamide (0, 25, 50, and
100 mg/ml).
Mean + SD of duplicate measurements of representative results from three independent experiments is depicted. *p < 0.05; **p < 0.01; p > 0.05 (n.s.). See also
Table S1.raised the possibility that a pharmacological intervention target-
ing ESX-1 function and hence EsxA release may be exploited to
selectively inhibit cGAS-mediated type I IFN responses while
leaving NLRP3-triggered IL-1b production intact. To prove this
hypothesis, we tested two small compounds, the benzothio-
phene inhibitor BTP15 and the benzyloxybenzylidene-hydrazine
compound BBH7, whichwe have recently identified as potent in-
hibitors of EsxA secretion in Mtb (Figure S5A) (Rybniker et al.,
2014). Treatment of Mtb with both BTP15 and BBH7 resulted in
significantly lower amounts of IP-10 production from infected
THP-1 cells (Figure 6D). In contrast, neither compound affected
the release of IL-1b (Figure 6D). Of note, a similar pattern was
observed in Mtb-infected primary human macrophages, where
a decrease in IP-10 was measured, while IL-1b was unaltered
(Figure 6E). In a control experiment, upon stimulation with DNA,
IL-1b responses were not altered in the presence of BTP15 and
BBH7, thereby confirming that both compounds inhibit Mtb and
not host functions (Figure S5B). Thus, we conclude that pharma-
cological manipulation of the ESX-1 secretion system can sway
theMtb-triggered immune cytokine pattern in favor of host-pro-
tective IL-1b production by accentuating intracellular sensing
via the inflammasome complex (Figure S6).
DISCUSSION
Our study demonstrated that in Mtb-infected cells cGAS is the
sole sensor driving the synthesis of type I IFNs and ISGs. We re-Cell Hvealed that infection of macrophages with virulent and attenu-
ated Mtb can engage distinct cytosolic PRR systems, namely
the cGAS-IFN-axis and the inflammasome-IL-1b-pathway, and
that the decision as to which pathway is triggered is determined
by the relative abundance of EsxA and/or by additional ESX-
1/EsxA-dependent effectors. Our results disclose an as-yet-
unnoticed interconnection between the mycobacterial virulence
factors and the cytokine pattern of mammalian cells.
The host protein STING has been identified as a central
signaling molecule in the innate immune response to various
pathogens, including DNA viruses, retroviruses, and intracellular
bacteria (Barber, 2014). During DNA virus or retrovirus infection
STING seems to carry out this function by being part of the intra-
cellular, cGAS-based DNA sensing pathway and by detecting
host-derived cGAMP (Sun et al., 2013; Gao et al., 2013). How-
ever, when considered in the context of intracellular bacterial
infection, such as withMtb, the role of STING and cGAS/cGAMP
is less consistent. Some authors have proposed that mycobac-
terial CDNs can be secreted into the cytosol and bind directly to
STING (Bai et al., 2012; Woodward et al., 2010). Another report
has proposed IFI204 as a putative DNA sensor forMtb in murine
BMDMs, where shRNA silencing of IFI204 resulted in reduced
expression levels of IFIT1 and IFN-b uponMtb infection (Manza-
nillo et al., 2012). Using both human and murine cGAS-deficient
cells, we clearly demonstrated that cGAS is critical for the induc-
tion of IFN-b after infection with Mtb. We found that cGAS and
intracellular DNA come together in the cytosol, supporting itsost & Microbe 17, 799–810, June 10, 2015 ª2015 Elsevier Inc. 805
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Figure 6. Selective Disruption of the ESX-1 Secretion System Uncouples Intracellular Recognition Pathways of Mtb
(A and B) THP-1 cells were infected with the following bacterial strains: Erdman (WT), Erdman espA::Tn/pMD31 (‘‘empty’’ in figure), Erdman espA::Tn/
pMDespACD, Erdman espC::Tn/pMD31, and Erdman espC::Tn/pMDespACD (moi 2.5, 5, and 10). After 24 hr IP-10 (A) and IL-1b (B) levels of the supernatants
were assessed by ELISA. (Upper right panel) Scheme of the espACD operon and the ESX-1 locus of the Mtb genome is depicted; RD1, region of difference 1.
(C) ELISAmeasurement of IL-1b in the supernatant of THP-1 cells after 24 hr of infection with the strains Erdman espA::Tn/pMD31 and Erdman espC::Tn/pMD31
(moi 10) in the presence of glibenclamide (Glib., 0, 25, 50, and 100 mg/ml).
(D) H37Rv was incubated with BTP15 (10 mM) or BBH7 (10 mM) for 24 hr. THP-1 cells were infected with the inhibitor-treated H37Rv (moi 10) as indicated or left
untreated (uninf.). After 24 hr, IP-10 and IL-1b production was quantified by ELISA.
(E) H37Rv was incubated with BTP15 (10 mM) or BBH7 (10 mM) for 24 hr. Primary human macrophages were infected with the inhibitor-treated H37Rv (moi 10) as
indicated or left untreated (uninf.). After 24 hr, IP-10 and IL-1b production was quantified by ELISA.
Representative results out of three (A–D) and two (E) independent experiments are depicted, whereas data are presented as mean + SD of duplicate mea-
surements. *p < 0.05; **p < 0.01; p > 0.05 (n.s.). See also Figure S5 and Table S1.role as a DNA receptor. As such, our study provides genetic
proof that cGAS is necessary to confer responsiveness to an
intracellular bacterial pathogen and indicates that at least in an806 Cell Host & Microbe 17, 799–810, June 10, 2015 ª2015 Elsevierex vivo setting mycobacterial-derived CDNs play a minor role,
if any, in triggering IFN-b gene upregulation. Notably, in parallel
to our own work, two independent studies by Chen, Shiloh,Inc.
and colleagues and Cox and colleagues, in this issue ofCell Host
&Microbe, report the same finding, that cGAS is essential for the
induction of type I IFN in Mtb-infected macrophages (Collins
et al., 2015; Watson et al., 2015).
Interestingly, we observed thatMtb can trigger the expression
of type I IFNseven in the absenceof an intact, cell-intrinsic cGAS-
cGAMP-STING signaling pathway. We explain this phenomenon
by the existence of an intercellular second-messenger-based
signaling network that exploits gap junctions to deliver cGAMP
into neighboring cells and thus complements the cGAS or STING
deficiency when mutant cell lines are cocultured (Ablasser et al.,
2013b). Indeed, the sensitivity of this phenomenon to carbenox-
olone treatment shown in thepresentwork confirms thegap junc-
tion dependency. In the lungs of infected mice, macrophages
have been reported to communicate immunomodulatory signals
via Ca2+ waves using gap junctions as the conducting pathway
(Westphalen et al., 2014). Future studies are needed to elucidate
whether in vivo cGAMP-based intercommunication might also
participate in modulating the immune response toMtb.
It is interesting to note that cells infected by the HN878 strain,
belonging to the W-Beijing lineage, but not by the H37Rv strain,
benefited from the cGAS-STING knockout when analyzed for
cell survival. This finding agrees with the literature, where a cor-
relation between IFN-b production and the virulence ofW-Beijing
strains has been established (Manca et al., 2001; 2005). More-
over, a recent investigation of the association between type
I IFN production and bacterial virulence demonstrated a role
for type I IFN in inducing the immunosuppressive cytokine
IL-10 and in repressing the cytoprotective effect of IFN-g in
Mtb-infected macrophages (McNab et al., 2014). These results
are consistent with our data, which show both strongly sup-
pressed production of IL-10 and enhanced macrophage survival
in cGAS knockout and STING knockout cells.
Mtb also elicits inflammatory responses, an event that is not
mediated by cGAS or STING but by the intracellular inflamma-
some complex. Interestingly, the inflammasome-mediated host
response also relies on the presence of cytosolic DNA, which
is sensed by AIM2 (Saiga et al., 2012; Hornung et al., 2009).
We proved that deletion of AIM2 causes reduction of IL-1b pro-
duction but that a significant inflammatory IL-1b signal is main-
tained via a functional NLRP3-dependent inflammasome system
(Dorhoi et al., 2012).
When characterizing the cytokine signature of several mutated
mycobacterial strains, we noticed that expression of type
I IFNs correlated with the secretion of the ESX-1 substrate
EsxA. Surprisingly, mutations compromising EsxA secretion
(as in H37Ra) did not affect inflammasome activation in the
same way, but instead shifted the Mtb-induced host response
toward the selective production of IL-1b. It has been generally
assumed that activation of the cGAS-STING-IFN-pathway and
the inflammasome-IL-1b-pathway in response to virulent myco-
bacteria is coregulated and triggered by a common (unknown)
mechanism mediated by ESX-1. Our work has now revealed
that intracellular host recognition pathways can be stimulated
differentially according to the level of EsxA secreted. Based on
the results obtained, we propose the following molecular expla-
nation. Strains H37RvDRD1 and H37RvDDRD1 lack the genes
for most of the ESX-1 secretion apparatus and its substrate
EsxA, and therefore they generate no measurable intracellularCell Hhost response. EsxA is still produced by the espA and espC
mutants and by H37Ra, but its secretion is not detectable
(Chen et al., 2013; Fortune et al., 2005; Frigui et al., 2008). How-
ever, a small amount of EsxA may be released intracellularly by
these bacteria, for instance by cell lysis, and this suffices to stim-
ulate production of IL-1b. In other words, EsxA levels shift the
host response either toward the detrimental cytokines (type
I IFN and downstream effectors) or toward the beneficial IL-1b.
In this sense, Solans et al. demonstrated that the reported de-
gree of virulence of variousMtb strains in guinea pigs correlates
with different levels of EsxA expression and secretion (Solans
et al., 2014) (Palanisamy et al., 2008). In accordance with this
explanation, W-Beijing strains, which secrete more EsxA (Solans
et al., 2014), elicit higher levels of IP-10, as demonstrated in this
work. This interpretation predicts that the specific expression of
distinct cytokine classes can be achieved by manipulating the
ESX-1 system. Indeed, we found that blocking EsxA secretion
by pharmacological means significantly downregulates IFN
expression yet still allows for robust production of IL-1b, as
further discussed below.
Insight into the mechanism of ESX-1-regulated innate immune
response is highly relevant for the development of vaccine
adjuvants or immunotherapeutics. Effective live vaccines have
to balance ‘‘harmlessness’’ with eliciting powerful and specific
immune responses. In this respect it is interesting to note that
the attenuatedMtb DphoPRmutant, which serves as the candi-
date TB vaccine, MTBVAC (Arbues et al., 2013), displays greatly
reduced secretion of EsxA (Frigui et al., 2008). One plausible
reason for the advantageous efficacy of MTBVAC involves its
ability to selectively trigger inflammatory cytokines and hence
to bypass the pathological consequences of the type I IFN
system. Alternatively, manipulating the IFN-b-IL-1 regulatory
cytokine network may represent a potential approach for the
treatment of established Mtb infection (Mayer-Barber et al.,
2014). Our finding that coregulation of the inflammasome-IL-
1b-pathway and the cGAS-IFN-b-pathway can be disconnected
via manipulation of the mycobacterial ESX-1 secretory system
could guide the development of a novel class of anti-TB drugs
for use in conjunction with conventional chemotherapy. As proof
of concept, our ex vivo data indicate that selective EsxA secre-
tion inhibitors (BTP15 or BBH7) can shift the innate immune cyto-
kine profile effectively toward the host-beneficial, antimicrobial
IL-1b direction. The experimental design, which involved pre-
treatment of the bacilli with BTP15 or BBH7 and thus preventive
depletion of EsxA, did not allow any reduction of IL-1b to be
observed, despite this being partly AIM2/DNA dependent. We
reason that intracellular Mtb multiplication was associated with
de novo secretion of EsxA. However, the levels of EsxA did not
reach those of the DMSO-treated bacteria, and we therefore
observed a decrease in IP-10 while IL-1b remained unaffected.
This confirms that wild-type levels of EsxA stimulate both type
I IFN and IL-1b, whereas a decrease in EsxA secretion mainly
affects type I IFN production while leaving the host-protective
IL-1b response virtually intact. This is corroborated by knocking
down EsxA secretion by genetic means in the espA and espC
mutants. In the latter cases, the amount of secreted EsxA is un-
detectable in vitro, and this is reflected in an even greater impact
on IP-10 and IL-1b as compared to chemical inhibition. Impor-
tantly, the data obtained with BTP15 and BBH7 directly correlateost & Microbe 17, 799–810, June 10, 2015 ª2015 Elsevier Inc. 807
with their level of protection of Mtb-infected fibroblasts, as
demonstrated recently (Rybniker et al., 2014). Future investiga-
tions will be required to see whether such a host-directed
anti-TB treatment may also prove to be successful in an in vivo
infection model.
EXPERIMENTAL PROCEDURES
Reagents and Plasmids
DNA oligonucleotides corresponding to the 90 bp long dsDNA (sense
sequence, 50-TACAGATCTACTAGTGATCTATGACTGATCTGTACATGATC
TACATACAGATCTACTAGTGATCTATGACTGATCTGTACATGATCTACA-30)
were obtained from Metabion and annealed in PBS. 50-triphosphate RNA
was prepared as previously described (Schlee et al., 2009). PMA (Phorbol
12-myristate 13-acetate), coelenterazine, chloroquine, carbenoxolone, and
DAPI were obtained from Sigma-Aldrich. Cyclic di-AMP and cGAMP (20-50)
were obtained from Biolog. Expression plasmids for Yybt and DacA
(Rv3586) were kind gifts from Professor Zhao-Xun Liang (School of Biological
Sciences, Nanyang Technological University) and Professor Guangchun Bai
(Center for Immunology and Microbial Disease, Albany Medical College),
respectively. An expression plasmid coding for human GFP-tagged cGAS
was previously described (Ablasser et al., 2013b). Expression plasmids cod-
ing for murine STING and human STING are based on pEFBOS (Ablasser
et al., 2013a).
CRISPR/CAS9-Mediated Knockout Cell Line Generation
THP-1 cells were coelectroporated with a gRNA- and a mCherry-Cas9-
expression plasmid as described (Schmid-Burgk et al., 2014). The gRNA
target sequences used were GAACTTTCCCGCCTTAGGCAGGG (cGAS), TCC
ATCCATCCCGTGTCCCAGGG (STING), GCTGGAGAACCTGACCGCCGAGG
(ASC), and TTTGGCAAAACGTCTTCAGGAGG (AIM2). After FACS enrichment
of mCherry-Cas9-positive cells, monoclones were grown out for 2 weeks and
were genotyped using deep sequencing as described. For each target gene,
two clones bearing all-allelic frameshift mutations were expanded for further
study.
Cell Line Generation by Lentiviral Transduction
The method for lentivirus-based expression of cGAS-Flag and GFP-Flag in
cGASmutated THP-1 cells was performed according to the standard protocol
(Barde et al., 2010). Stable cGAS- or GFP-expressing cell lines were generated
under puromycin selection.
Cell Culture
HEK293T cells were cultured in DMEM and human macrophages (CD14+ cells
differentiated with GM-CSF [20 ng/ml]), and PMA-activated THP-1 cells were
cultured in RPMI1640, both supplemented with 10% (v/v) FCS, sodium pyru-
vate (all Life Technologies), and Ciprofloxacin (Bayer Schering Pharma).
BMDMs were generated using L929-cell-conditioned medium (LCCM) as a
source of granulocyte/macrophage colony stimulating factor. cGAS/ mice
were generated in the laboratory of Charles M. Rice (Schoggins et al., 2014).
For the generation of human macrophages, PBMCs were obtained by Fi-
coll–Hypaque density gradient centrifugation, and CD14+ cells were isolated
by MACS using the CD14+ cell isolation kit (Miltenyi Biotech) according to
the manufacturer’s instructions. Buffy coats were obtained from the blood
transfusion center (Centre de Transfusion Interre´gionale, Croix Rouge Suisse),
and the experiments were approved by the Office Ethical Committee (Com-
mission Cantonale D’e´thique de la Recherche) with the authorization number
107/15.
Cell Stimulation and Transient Transfection
Murine BMDMs (1 3 106/ml), THP-1 cells (1 3 106/ml), and human macro-
phages (1 3 106/ml) were transfected using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. HEK293T cells (2 3 105/ml)
were transfected using GeneJuice (Novagen) according to the manufacturer’s
instructions. DsDNA and 50-triphosphate RNA were transfected at a final con-
centration of 1.33 mg/ml. CDNs were transfected at a final concentration of
2 mg/ml.808 Cell Host & Microbe 17, 799–810, June 10, 2015 ª2015 ElsevierBacterial Strains and Culture Conditions
Mtb strains (described in Table S1) were grown at 37C in 7H9 medium (Difco)
supplemented with 0.2% glycerol, 0.05% Tween 80, and 10% albumin-
dextrose-catalase (ADC, Middlebrook) or on 7H10 plates supplemented with
0.5% glycerol and 10% oleic acid-albumin-dextrose-catalase (OADC, Middle-
brook). Kanamycin (20 mg/ml) and hygromycin (50 mg/ml) were used when
necessary.
Preparation of Mycobacterium tuberculosis Cultures for Cell
Infection
Bacteria were grown to exponential phase (optical density at 600 nm, OD600,
between 0.4 and 0.8), washed once in 7H9 medium, resuspended in 7H9 to an
OD600 of 1, equivalent to 3 3 10
8 bacteria/ml. The required volume of Mtb
bacterial suspension was then added to RPMI1640 or DMEM for infection of
human THP-1 cells or mouse BMDM, respectively, at the multiplicity of infec-
tion (moi) reported in the text. Plates were sealed with gas-permeable sealing
film and incubated at 37C under 5% CO2.
Cell Viability Assay
CellTiter-Blue Assay (Promega) was performed according to the manufac-
turer’s instructions.
Immunofluorescence Microscopy
THP-1 cells were activated with 100 ng/ml PMA and seeded on coverslips
in 24-well plates. Cells were then either transfected with the indicated
nucleic acids, CDNs, or infected with Mtb for indicated time periods. After
incubation cells were fixed with 4% formaldehyde in PBS for 20 min at
25C. Cells were then blocked and permeabilized in blocking buffer (2%
BSA, 0.2% Triton X-100 in PBS) for 30 min. Cells were stained with anti-
Flag (Sigma), anti-Beclin-1 (Cell Signaling), anti-ASC (Santa Cruz), Texas
Red anti-rabbit, and Alexa Fluor 488 anti-mouse antibodies (Life Technolo-
gies) for 1 hr at 25C. Imaging was performed using the Zeiss Axioplan fluo-
rescence microscope.
Immunoblotting
Cells were lysed in 13 Laemmli buffer and denatured at 95 C for 5 min. Cell
lysates were separated by 10%SDS-PAGE and transferred onto nitrocellulose
membranes. Blots were incubated with anti-STING (Cell Signaling), anti-
MB21D1 (anti-cGAS, Sigma-Aldrich), anti-b-actin-HRP, and anti-rabbit-IgG-
HRP (both Santa Cruz Biotechnology).
Luciferase Reporter Assays
HEK293T cells (2 3 104 cells in each well of a 96-well plate) were transiently
transfected with 25 ng IFN-b promoter reporter plasmid (pIFN-B-Gluc) in
conjunction with expression vectors as indicated using GeneJuice (Novagen).
cGAS was used to induce cGAMP production, and DacA was used to induce
cyclic di-AMP production within HEK293T cells upon transient overexpres-
sion. Luciferase activity was assessed in the supernatants 14–20 hr posttrans-
fection with coelenterazine (2.2 mM) as substrate.
ELISA
Cell culture supernatants were removed from infected or transfected cells after
24 hr. In the case of infection, supernatants were filtered through NANOSEP
centrifugal devices (Life Sciences) and assayed for mouse IP-10 (R&D Sys-
tems), human IP-10, IL-1b, TNF-a, IL-10 (BD Biosciences), and IFN-b (PBL
Interferon Source) according to the manufacturer’s instructions.
Analysis of Murine Type I IFN Production via Bioassay
Mouse type I IFN levels were determined by incubating LL171 cells with super-
natants from infected BMDMs for 4 hr. Luciferase activity was measured, and
type I IFN levels were calculated using a dilution series of the standard.
qPCR
RNA from cells was reverse transcribed using the RevertAid First Strand cDNA
Synthesis kit (Fermentas), and quantitative PCR analysis was performed on an
ABI 7900HT. All gene expression data are presented as relative expression to
GAPDH. The sequences were as follows: GAPDH forward, 50-GAGTCAACG
GATTTGGTCGT-30; GAPDH reverse, 50-GACAAGCTTCCCGTTCTCAG-30;Inc.
IFNB1 forward, 50-CAGCATCTGCTGGTTGAAGA-30; IFNB1 reverse, 50-CAT
TACCTGAAGGCCAAGGA-30; IFIT2 forward, 50-GCGTGAAGAAGGTGAAG
AGG-30; and IFIT2 reverse, 50-GCAGGTAGGCATTGTTTGGT-30.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and one table and can be found
with this article at http://dx.doi.org/10.1016/j.chom.2015.05.003.
AUTHOR CONTRIBUTIONS
R.W., M.F.G., C.S., S.G.P., Y.L., J.R., and A.A. performed experiments. R.W.,
M.F.G., C.S., Y.L., J.R., A.A., and S.T.C. designed experiments and analyzed
the data. J.L.S.-B., T.S., and V.H. developed the CRISPR/Cas9 targeting strat-
egy. R.W., M.F.G., C.S., S.T.C., and A.A. wrote the manuscript with input and
approval from all authors. S.T.C. and A.A. supervised the project.
ACKNOWLEDGMENTS
We thank J. Chen, D. Bottai, and R. Brosch for providing strains and A. Roers
and J. Schoggins for knockout mice. This work was supported by the Swiss
National Science Foundation (grant numbers 31003A_159836 [A.A.] and
31003A_140778 [S.T.C.]) and by the Else Kro¨ner-Fresenius-Stiftung (grant
number 2014_A250 [A.A.]). J.R. and S.T.C. are named inventors on a patent
pertaining to this work.
Received: December 2, 2014
Revised: March 2, 2015
Accepted: April 15, 2015
Published: June 2, 2015
REFERENCES
Ablasser, A., Goldeck, M., Cavlar, T., Deimling, T., Witte, G., Ro¨hl, I., Hopfner,
K.P., Ludwig, J., and Hornung, V. (2013a). cGAS produces a 20-50-linked cyclic
dinucleotide second messenger that activates STING. Nature 498, 380–384.
Ablasser, A., Schmid-Burgk, J.L., Hemmerling, I., Horvath, G.L., Schmidt, T.,
Latz, E., and Hornung, V. (2013b). Cell intrinsic immunity spreads to bystander
cells via the intercellular transfer of cGAMP. Nature 503, 530–534.
Arbues, A., Aguilo, J.I., Gonzalo-Asensio, J., Marinova, D., Uranga, S.,
Puentes, E., Fernandez, C., Parra, A., Cardona, P.J., Vilaplana, C., et al.
(2013). Construction, characterization and preclinical evaluation of MTBVAC,
the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials.
Vaccine 31, 4867–4873.
Bai, Y., Yang, J., Zhou, X., Ding, X., Eisele, L.E., and Bai, G. (2012).
Mycobacterium tuberculosis Rv3586 (DacA) is a diadenylate cyclase that
converts ATP or ADP into c-di-AMP. PLoS ONE 7, e35206.
Barber, G.N. (2014). STING-dependent cytosolic DNA sensing pathways.
Trends Immunol. 35, 88–93.
Barde, I., Salmon, P., and Trono, D. (2010). Production and titration of lentiviral
vectors. Curr. Protoc. Neurosci. Chapter 4. Unit 4, 21.
Berry, M.P., Graham, C.M., McNab, F.W., Xu, Z., Bloch, S.A., Oni, T.,
Wilkinson, K.A., Banchereau, R., Skinner, J., Wilkinson, R.J., et al. (2010). An
interferon-inducible neutrophil-driven blood transcriptional signature in human
tuberculosis. Nature 466, 973–977.
Bottai, D., Majlessi, L., Simeone, R., Frigui, W., Laurent, C., Lenormand, P.,
Chen, J., Rosenkrands, I., Huerre, M., Leclerc, C., et al. (2011). ESAT-6 secre-
tion-independent impact of ESX-1 genes espF and espG1 on virulence of
Mycobacterium tuberculosis. J. Infect. Dis. 203, 1155–1164.
Burdette, D.L., Monroe, K.M., Sotelo-Troha, K., Iwig, J.S., Eckert, B., Hyodo,
M., Hayakawa, Y., and Vance, R.E. (2011). STING is a direct innate immune
sensor of cyclic di-GMP. Nature 478, 515–518.
Chen, J.M., Boy-Ro¨ttger, S., Dhar, N., Sweeney, N., Buxton, R.S., Pojer, F.,
Rosenkrands, I., and Cole, S.T. (2012). EspD is critical for the virulence-medi-
ating ESX-1 secretion system in Mycobacterium tuberculosis. J. Bacteriol.
194, 884–893.Cell HChen, J.M., Zhang, M., Rybniker, J., Boy-Ro¨ttger, S., Dhar, N., Pojer, F., and
Cole, S.T. (2013). Mycobacterium tuberculosis EspB binds phospholipids
and mediates EsxA-independent virulence. Mol. Microbiol. 89, 1154–1166.
Collins, A., Cai, H., Li, T., Franco, L., Li, X.-D., Nair, V., Scharn, C., Stamm, C.,
Levine, B., Chen, Z., et al. (2015). Cyclic GMP-AMP synthase is an innate
immune sensor of Mycobacterium tuberculosis DNA. Cell Host Microbe 17,
this issue, 820–828.
Dorhoi, A., Nouailles, G., Jo¨rg, S., Hagens, K., Heinemann, E., Pradl, L.,
Oberbeck-Mu¨ller, D., Duque-Correa, M.A., Reece, S.T., Ruland, J., et al.
(2012). Activation of the NLRP3 inflammasome by Mycobacterium tubercu-
losis is uncoupled from susceptibility to active tuberculosis. Eur. J. Immunol.
42, 374–384.
Fortune, S.M., Jaeger, A., Sarracino, D.A., Chase, M.R., Sassetti, C.M.,
Sherman, D.R., Bloom, B.R., and Rubin, E.J. (2005). Mutually dependent
secretion of proteins required for mycobacterial virulence. Proc. Natl. Acad.
Sci. USA 102, 10676–10681.
Fremond, C.M., Togbe, D., Doz, E., Rose, S., Vasseur, V., Maillet, I., Jacobs,
M., Ryffel, B., and Quesniaux, V.F. (2007). IL-1 receptor-mediated signal
is an essential component of MyD88-dependent innate response to
Mycobacterium tuberculosis infection. J. Immunol. 179, 1178–1189.
Frigui, W., Bottai, D., Majlessi, L., Monot, M., Josselin, E., Brodin, P., Garnier,
T., Gicquel, B., Martin, C., Leclerc, C., et al. (2008). Control of M. tuberculosis
ESAT-6 secretion and specific T cell recognition by PhoP. PLoS Pathog. 4,
e33.
Gao, D., Wu, J., Wu, Y.T., Du, F., Aroh, C., Yan, N., Sun, L., and Chen, Z.J.
(2013). Cyclic GMP-AMP synthase is an innate immune sensor of HIV and
other retroviruses. Science 341, 903–906.
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G.,
Caffrey, D.R., Latz, E., and Fitzgerald, K.A. (2009). AIM2 recognizes cytosolic
dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature
458, 514–518.
Kurenuma, T., Kawamura, I., Hara, H., Uchiyama, R., Daim, S., Dewamitta,
S.R., Sakai, S., Tsuchiya, K., Nomura, T., and Mitsuyama, M. (2009). The
RD1 locus in the Mycobacterium tuberculosis genome contributes to activa-
tion of caspase-1 via induction of potassium ion efflux in infected macro-
phages. Infect. Immun. 77, 3992–4001.
Lechartier, B., Rybniker, J., Zumla, A., and Cole, S.T. (2014). Tuberculosis drug
discovery in the post-post-genomic era. EMBO Mol. Med. 6, 158–168.
Liang, Q., Seo, G.J., Choi, Y.J., Kwak, M.J., Ge, J., Rodgers, M.A., Shi, M.,
Leslie, B.J., Hopfner, K.P., Ha, T., et al. (2014). Crosstalk between the cGAS
DNA sensor and Beclin-1 autophagy protein shapes innate antimicrobial
immune responses. Cell Host Microbe 15, 228–238.
Manca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J.M.,
Barry, C.E., 3rd, Freedman, V.H., and Kaplan, G. (2001). Virulence of a
Mycobacterium tuberculosis clinical isolate in mice is determined by failure
to induce Th1 type immunity and is associated with induction of IFN-alpha/
beta. Proc. Natl. Acad. Sci. USA 98, 5752–5757.
Manca, C., Tsenova, L., Freeman, S., Barczak, A.K., Tovey, M., Murray, P.J.,
Barry, C., and Kaplan, G. (2005). Hypervirulent M. tuberculosis W/Beijing
strains upregulate type I IFNs and increase expression of negative regulators
of the Jak-Stat pathway. J. Interferon Cytokine Res. 25, 694–701.
Manzanillo, P.S., Shiloh, M.U., Portnoy, D.A., and Cox, J.S. (2012).
Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveil-
lance pathway within macrophages. Cell Host Microbe 11, 469–480.
Mayer-Barber, K.D., Andrade, B.B., Barber, D.L., Hieny, S., Feng, C.G.,
Caspar, P., Oland, S., Gordon, S., and Sher, A. (2011). Innate and adaptive in-
terferons suppress IL-1a and IL-1b production by distinct pulmonary myeloid
subsets during Mycobacterium tuberculosis infection. Immunity 35, 1023–
1034.
Mayer-Barber, K.D., Andrade, B.B., Oland, S.D., Amaral, E.P., Barber, D.L.,
Gonzales, J., Derrick, S.C., Shi, R., Kumar, N.P., Wei, W., et al. (2014). Host-
directed therapy of tuberculosis based on interleukin-1 and type I interferon
crosstalk. Nature 511, 99–103.ost & Microbe 17, 799–810, June 10, 2015 ª2015 Elsevier Inc. 809
McNab, F.W., Ewbank, J., Howes, A., Moreira-Teixeira, L., Martirosyan, A.,
Ghilardi, N., Saraiva, M., and O’Garra, A. (2014). Type I IFN induces IL-10 pro-
duction in an IL-27-independent manner and blocks responsiveness to IFN-g
for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-
infected macrophages. J. Immunol. 193, 3600–3612.
Mishra, B.B., Moura-Alves, P., Sonawane, A., Hacohen, N., Griffiths, G., Moita,
L.F., and Anes, E. (2010). Mycobacterium tuberculosis protein ESAT-6 is
a potent activator of the NLRP3/ASC inflammasome. Cell. Microbiol. 12,
1046–1063.
O’Garra, A., Redford, P.S., McNab, F.W., Bloom, C.I., Wilkinson, R.J., and
Berry, M.P. (2013). The immune response in tuberculosis. Annu. Rev.
Immunol. 31, 475–527.
Palanisamy, G.S., Smith, E.E., Shanley, C.A., Ordway, D.J., Orme, I.M., and
Basaraba, R.J. (2008). Disseminated disease severity as a measure of viru-
lence of Mycobacterium tuberculosis in the guinea pig model. Tuberculosis
(Edinb.) 88, 295–306.
Pym, A.S., Brodin, P., Brosch, R., Huerre, M., and Cole, S.T. (2002). Loss of
RD1 contributed to the attenuation of the live tuberculosis vaccines
Mycobacterium bovis BCG and Mycobacterium microti. Mol. Microbiol. 46,
709–717.
Rao, F., See, R.Y., Zhang, D., Toh, D.C., Ji, Q., and Liang, Z.X. (2010). YybT is a
signaling protein that contains a cyclic dinucleotide phosphodiesterase
domain and a GGDEF domain with ATPase activity. J. Biol. Chem. 285,
473–482.
Reed, M.B., Gagneux, S., Deriemer, K., Small, P.M., and Barry, C.E., 3rd.
(2007). The W-Beijing lineage of Mycobacterium tuberculosis overproduces
triglycerides and has the DosR dormancy regulon constitutively upregulated.
J. Bacteriol. 189, 2583–2589.
Rybniker, J., Chen, J.M., Sala, C., Hartkoorn, R.C., Vocat, A., Benjak, A., Boy-
Ro¨ttger, S., Zhang, M., Sze´kely, R., Greff, Z., et al. (2014). Anticytolytic screen
identifies inhibitors of mycobacterial virulence protein secretion. Cell Host
Microbe 16, 538–548.
Saiga, H., Kitada, S., Shimada, Y., Kamiyama, N., Okuyama, M., Makino, M.,
Yamamoto, M., and Takeda, K. (2012). Critical role of AIM2 in
Mycobacterium tuberculosis infection. Int. Immunol. 24, 637–644.810 Cell Host & Microbe 17, 799–810, June 10, 2015 ª2015 ElsevierSchlee, M., Roth, A., Hornung, V., Hagmann, C.A., Wimmenauer, V., Barchet,
W., Coch, C., Janke, M., Mihailovic, A., Wardle, G., et al. (2009). Recognition of
50 triphosphate by RIG-I helicase requires short blunt double-stranded RNA as
contained in panhandle of negative-strand virus. Immunity 31, 25–34.
Schmid-Burgk, J.L., Schmidt, T., Gaidt, M.M., Pelka, K., Latz, E., Ebert, T.S.,
and Hornung, V. (2014). OutKnocker: a web tool for rapid and simple genotyp-
ing of designer nuclease edited cell lines. Genome Res. 24, 1719–1723.
Schoggins, J.W., MacDuff, D.A., Imanaka, N., Gainey, M.D., Shrestha, B.,
Eitson, J.L., Mar, K.B., Richardson, R.B., Ratushny, A.V., Litvak, V., et al.
(2014). Pan-viral specificity of IFN-induced genes reveals new roles for
cGAS in innate immunity. Nature 505, 691–695.
Solans, L., Aguilo´, N., Samper, S., Pawlik, A., Frigui, W., Martı´n, C., Brosch, R.,
and Gonzalo-Asensio, J. (2014). A specific polymorphism in Mycobacterium
tuberculosis H37Rv causes differential ESAT-6 expression and identifies
WhiB6 as a novel ESX-1 component. Infect. Immun. 82, 3446–3456.
Stanley, S.A., Johndrow, J.E., Manzanillo, P., and Cox, J.S. (2007). The Type I
IFN response to infection with Mycobacterium tuberculosis requires ESX-1-
mediated secretion and contributes to pathogenesis. J. Immunol. 178,
3143–3152.
Stoop, E.J., Bitter, W., and van der Sar, A.M. (2012). Tubercle bacilli rely on a
type VII army for pathogenicity. Trends Microbiol. 20, 477–484.
Sun, L., Wu, J., Du, F., Chen, X., and Chen, Z.J. (2013). Cyclic GMP-AMP syn-
thase is a cytosolic DNA sensor that activates the type I interferon pathway.
Science 339, 786–791.
Watson, R.O., Bell, S.L., MacDuff, D.A., Kimmey, J.M., Diner, E.J., Olivas, J.,
Vance, R.E., Stallings, C.L., Virgin, H.W., and Cox, J.S. (2015). The cytosolic
sensor cGAS detects Mycobacterium tuberculosis DNA to induce type I inter-
ferons and activate autophagy. Cell Host Microbe 17, this issue, 811–819.
Westphalen, K., Gusarova, G.A., Islam, M.N., Subramanian, M., Cohen, T.S.,
Prince, A.S., and Bhattacharya, J. (2014). Sessile alveolar macrophages
communicate with alveolar epithelium to modulate immunity. Nature 506,
503–506.
Woodward, J.J., Iavarone, A.T., and Portnoy, D.A. (2010). c-di-AMP secreted
by intracellular Listeria monocytogenes activates a host type I interferon
response. Science 328, 1703–1705.Inc.
